Jonathan Siegel

Insider profile

Currently holds positions in Amag Pharma Usa Inc and Jaguar Health Inc

Positions

Position Company Period
Director Amag Pharma Usa Inc Sept. 16, 2013 -
Independent Director Jaguar Health Inc Dec. 1, 2018 -
Director Jaguar Health Inc March 29, 2018 - Dec. 1, 2018
Jonathan Siegel's trades of Jaguar Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
15.67
Quantity 50,688 +18.4%
Value US$2,162,684
Transaction date
Purchase
Price
285.75
Quantity 4,695 +22.7%
Value US$4,903,515
Transaction date
Purchase
Price
412.39
Quantity 61,968 -39.9%
Value US$137,919
Transaction date
Purchase
Price
1.19
Quantity 2,232 +29.8%
Value US$2,656
Transaction date
Purchase
Price
1.36
Quantity 7,500 +336.0%
Value US$10,190
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-25 2019-07-23
B Purchase
50,688 +18.4%
15.67
US$2,162,684 		50,688 +18.4% 15.67 US$2,162,684
2018-10-05 2018-10-04
B Purchase
4,695 +22.7%
285.75
US$4,903,515 		4,695 +22.7% 285.75 US$4,903,515
2018-07-20 2018-07-18
B Purchase
61,968 -39.9%
412.39
US$137,919 		61,968 -39.9% 412.39 US$137,919
2018-07-18 2018-07-17
B Purchase
2,232 +29.8%
1.19
US$2,656 		2,232 +29.8% 1.19 US$2,656
2018-07-18 2018-07-16
B Purchase
7,500 +336.0%
1.36
US$10,190 		7,500 +336.0% 1.36 US$10,190